Stocks
Mutual Funds
ETFs
Pro Tools
Terminal
WealthView
Pricing
Learn More
stocks
CTLLAB
CTLLAB

Clinitech Laboratory Ltd.

BSE: 544220
SME
Sector: Healthcare
Industry Group: Healthcare Services
40.00+0.0 (+0.00%)
10 Jul, 12:00 AM

Stock Scores

Quality Score

Score not available

Value Score

Score not available

Price Momentum Score

Score not available

QVM Score

Score not available

Key Metrics

Market Cap
9.13
P/E (TTM)
22.01
P/B
0.99
P/S (TTM)
0.96
EV/EBITDA
7.65
CAPE (5Y)
19.45
ROE (TTM)
4.59
ROCE (TTM)
5.13
ROA (TTM)
3.79
Avg 3Y ROE
7.83
Earnings 3Y CAGR
-12.01
Sales 3Y CAGR
14.35
Sales 5Y CAGR
15.82
Debt/Equity
0.06
Consensus TP
-
Strong Buy %
-
Promoter Holding
64.20
Pledged %
0.00

Share Price

Track Clinitech Laboratory Ltd.'s current share price, historical price chart, 52-week high/low, and performance across different time periods.

1 Week returns: -4.76 %
Low
40.0
High
40.0
1 Month returns: 5.26 %
Low
39.3
High
45.6
1 Year returns: 18.34 %
Low
28.6
High
57.0
3 Year CAGR: –
5 Year CAGR: –
Note: Prices may be delayed by a few minutes. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.

Financial Snapshot

See detailed analysis

Multi-year trends for Clinitech Laboratory Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Clinitech Laboratory Ltd. Shareholding Pattern

Quarterly breakdown of Clinitech Laboratory Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Clinitech Laboratory Ltd. shares as reported to NSE and BSE.

Frequently Asked Questions

What is the current share price of Clinitech Laboratory Ltd.?
The current share price of Clinitech Laboratory Ltd. is ₹ 40.00 as of 10 Jul 2026.
What is the market capitalisation of Clinitech Laboratory Ltd.?
The market capitalisation of Clinitech Laboratory Ltd. stands at ₹ 9.13 Cr.
What is the PE ratio of Clinitech Laboratory Ltd.?
The Price-to-Earnings (PE) ratio of Clinitech Laboratory Ltd. is 22.01 as of the latest trailing twelve months data.
What is the ROE and ROCE of Clinitech Laboratory Ltd.?
Clinitech Laboratory Ltd. has a Return on Equity (ROE) of 4.59% and a Return on Capital Employed (ROCE) of 5.13% as per the latest financial reports.
What is the 52-week high and low of Clinitech Laboratory Ltd.?
The 52-week high of Clinitech Laboratory Ltd. is - and the 52-week low is -.
What is the dividend yield of Clinitech Laboratory Ltd.?
The dividend yield of Clinitech Laboratory Ltd. is 0.00% based on the current market price.
What is the FII and DII holding in Clinitech Laboratory Ltd.?
Foreign Institutional Investors (FII) hold 0.32%, Domestic Institutional Investors (DII) hold 0.00% and retail/public investors hold 35.48% of Clinitech Laboratory Ltd. shares.
What sector does Clinitech Laboratory Ltd. belong to?
Clinitech Laboratory Ltd. operates in the Healthcare sector.
What is the beta of Clinitech Laboratory Ltd.?
The beta of Clinitech Laboratory Ltd. is 0.82, indicating its price volatility relative to the broader market.
What is the RSI of Clinitech Laboratory Ltd.?
The 14-day Relative Strength Index (RSI) of Clinitech Laboratory Ltd. is 49.57, placing it in the neutral zone. An RSI above 70 is considered overbought and below 30 is considered oversold.